401 related articles for article (PubMed ID: 33608902)
41. Species distribution and antifungal susceptibility profile of Candida isolates from blood and other normally sterile foci from pediatric ICU patients in Tehran, Iran.
Mirhendi H; Charsizadeh A; Eshaghi H; Nikmanesh B; Arendrup MC
Med Mycol; 2020 Feb; 58(2):201-206. PubMed ID: 31111910
[TBL] [Abstract][Full Text] [Related]
42. Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.
Wu PF; Liu WL; Hsieh MH; Hii IM; Lee YL; Lin YT; Ho MW; Liu CE; Chen YH; Wang FD
Emerg Microbes Infect; 2017 Oct; 6(10):e87. PubMed ID: 29018251
[TBL] [Abstract][Full Text] [Related]
43. APX001A
Arendrup MC; Chowdhary A; Astvad KMT; Jørgensen KM
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30104264
[TBL] [Abstract][Full Text] [Related]
44. Bacterial lipopolysaccharides variably modulate in vitro biofilm formation of Candida species.
Bandara HMHN; Lam OLT; Watt RM; Jin LJ; Samaranayake LP
J Med Microbiol; 2010 Oct; 59(Pt 10):1225-1234. PubMed ID: 20576747
[TBL] [Abstract][Full Text] [Related]
45. Silicone colonization by non-Candida albicans Candida species in the presence of urine.
Silva S; Negri M; Henriques M; Oliveira R; Williams D; Azeredo J
J Med Microbiol; 2010 Jul; 59(Pt 7):747-754. PubMed ID: 20299506
[TBL] [Abstract][Full Text] [Related]
46. [Evaluation of PNA-FISH method for direct identification of Candida species in blood culture samples and its potential impact on guidance of antifungal therapy].
Doğan Ö; İnkaya AÇ; Gülmez D; Uzun Ö; Akova M; Arıkan Akdağlı S
Mikrobiyol Bul; 2016 Oct; 50(4):580-589. PubMed ID: 28124963
[TBL] [Abstract][Full Text] [Related]
47. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
48. In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms.
Rukayadi Y; Han S; Yong D; Hwang JK
Med Mycol; 2011 Jan; 49(1):1-9. PubMed ID: 20560862
[TBL] [Abstract][Full Text] [Related]
49. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
50. Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Brilhante RSN; Bittencourt PV; de Souza Collares Castelo-Branco D; de Melo Guedes GM; de Oliveira JS; Alencar LP; de Aguiar Cordeiro R; Pinheiro M; Nogueira-Filho EF; de Aquino Pereira-Neto W; Sidrim JJC; Rocha MFG
Vet Ophthalmol; 2017 Nov; 20(6):539-546. PubMed ID: 28417524
[TBL] [Abstract][Full Text] [Related]
51. Antifungal susceptibility of invasive Candida bloodstream isolates from the Asia-Pacific region.
Tan TY; Hsu LY; Alejandria MM; Chaiwarith R; Chinniah T; Chayakulkeeree M; Choudhury S; Chen YH; Shin JH; Kiratisin P; Mendoza M; Prabhu K; Supparatpinyo K; Tan AL; Phan XT; Tran TT; Nguyen GB; Doan MP; Huynh VA; Nguyen SM; Tran TB; Van Pham H
Med Mycol; 2016 Jul; 54(5):471-7. PubMed ID: 26868904
[TBL] [Abstract][Full Text] [Related]
52. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
53. Biofilm as a virulence marker in Candida species in Nosocomial blood stream infection and its correlation with antifungal resistance.
Bhatt M; Sarangi G; Paty BP; Mohapatra D; Chayani N; Mahapatra A; Das P; Sahoo D
Indian J Med Microbiol; 2015 Feb; 33 Suppl():112-4. PubMed ID: 25657126
[TBL] [Abstract][Full Text] [Related]
54. Highly efficient antibiofilm and antifungal activity of green propolis against Candida species in dentistry materials.
Bezerra CRF; Assunção Borges KR; Alves RNS; Teles AM; Pimentel Rodrigues IV; da Silva MACN; Nascimento MDDSB; Bezerra GFB
PLoS One; 2020; 15(12):e0228828. PubMed ID: 33362254
[TBL] [Abstract][Full Text] [Related]
55. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
56. Is biofilm production a predictor of catheter-related candidemia?
Guembe M; Guinea J; Marcos-Zambrano L; Fernández-Cruz A; Peláez T; Muñoz P; Bouza E
Med Mycol; 2014 May; 52(4):407-10. PubMed ID: 24782103
[TBL] [Abstract][Full Text] [Related]
57. A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.
Rodriguez L; Bustamante B; Huaroto L; Agurto C; Illescas R; Ramirez R; Diaz A; Hidalgo J
PLoS One; 2017; 12(4):e0175172. PubMed ID: 28419092
[TBL] [Abstract][Full Text] [Related]
58. Hedera rhombea inhibits the biofilm formation of Candida, thereby increases the susceptibility to antifungal agent, and reduces infection.
Kim D; Kim KY
PLoS One; 2021; 16(10):e0258108. PubMed ID: 34614005
[TBL] [Abstract][Full Text] [Related]
59. Changing epidemiology of candidemia in a medical center in middle Taiwan.
Hii IM; Chang HL; Lin LC; Lee YL; Liu YM; Liu CE; Chen CH; Cheng YR; Chang CY
J Microbiol Immunol Infect; 2015 Jun; 48(3):306-15. PubMed ID: 24113067
[TBL] [Abstract][Full Text] [Related]
60. Effect of the molecular weight of chitosan on its antifungal activity against Candida spp. in planktonic cells and biofilm.
Garcia LGS; Guedes GMM; da Silva MLQ; Castelo-Branco DSCM; Sidrim JJC; Cordeiro RA; Rocha MFG; Vieira RS; Brilhante RSN
Carbohydr Polym; 2018 Sep; 195():662-669. PubMed ID: 29805025
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
